Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis

Biochemical and Biophysical Research Communications

Volumn 468, Issue 1-2, 2015, Pages 240-247

  Ueno, Hideaki ^a,b,c   Tomiyama, Arata ^a,b   Yamaguchi, Hideki ^b   Uekita, Takamasa ^d   Shirakihara, Takuya ^b   Nakashima, Katsuhiko ^b   Otani, Naoki ^a   Wada, Kojiro ^a   Sakai, Ryuichi ^b   Arai, Hajime ^c   Mori, Kentaro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL DEFENSE ACADEMY   (Japan)

Author keywords

Glioma; Invadopodia; Invasion; JNK; Paxillin; Temozolomide resistance

Indexed keywords

F ACTIN; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; SERINE; STRESS ACTIVATED PROTEIN KINASE; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE;

ARTICLE; CELL ACTIVATION; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DEGRADATION; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; INVADOPODIA; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANALOGS AND DERIVATIVES; CELL MOTION; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PODOSOME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; CELL MOVEMENT; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GLIOMA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PAXILLIN; PHOSPHORYLATION; PODOSOMES; SIGNAL TRANSDUCTION;

EID: 84947763888     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.10.122     Document Type: Article

References (27)

1. A.A. Brandes, E. Franceschi, A. Tosoni, and et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients J. Clin. Oncol. 26 2008 2192 2197
2. D.A. Murphy, and S.A. Courtneidge The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function Nat. Rev. Mol. Cell. Biol. 12 2011 413 426 Review
3. H. Yamaguchi, and T. Oikawa Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis Oncotarget 1 2010 320 328 Review
4. C. Bubici, and S. Papa JNK signalling in cancer: in need of new, smarter therapeutic targets Br. J. Pharmacol. 171 2014 24 37 Review
5. Y.Y. Lei, W.J. Wang, J.H. Mei, and et al. Mitogen-activated protein kinase signal transduction in solid tumors Asian Pac. J. Cancer Prev. 15 2014 8539 8548 Review
6. Q.R. Liu, J.M. Liu, Y. Chen, and et al. Piperlongumine inhibits migration of glioblastoma cells via activation of ROS-dependent p38 and JNK signaling pathways Oxid. Med. Cell Longev. 2014 653732
7. X. Zhou, L. Hua, W. Zhang, and et al. FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling J. Neurooncol. 110 2012 9 19
8. C.E. Turner, J.R. Glenney Jr., and K. Burridge Paxillin: a new vinculin-binding protein present in focal adhesions J. Cell Biol. 111 1990 1059 1068
9. D.L. Chen, D.S. Wang, W.J. Wu, and et al. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer Carcinogenesis 34 2013 803 811
10. T. Du, Y. Qu, J. Li, and et al. Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway Mol. Cancer 13 2014 100
11. P. Kratimenos, I. Koutroulis, D. Marconi, and et al. Multi-targeted molecular therapeutic approach in aggressive neuroblastoma: the effect of Focal Adhesion Kinase-Src-Paxillin system Expert Opin. Ther. Targets 18 2014 1395 1406
12. C. Huang, Z. Rajfur, C. Borchers, and et al. JNK phosphorylates paxillin and regulates cell migration Nature 424 2003 219 223
13. K. Azuma, M. Tanaka, T. Uekita, and et al. Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma Oncogene 24 2005 4754 4764
14. A. Tomiyama, T. Uekita, R. Kamata, and et al. Flotillin-1 regulates oncogenic signaling in neuroblastoma cells by regulating ALK membrane association Cancer Res. 74 2014 3790 3801
15. H. Yamaguchi, S. Yoshida, E. Muroi, and et al. Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation J. Cell Biol. 193 2011 1275 1288
16. S. Ohba, Y. Hirose, T. Kawase, and et al. Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells J. Neurooncol. 95 2009 307 316
17. B.L. Bennett, D.T. Sasaki, B.W. Murray, and et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Proc. Natl. Acad. Sci. U. S. A. 98 2001 13681 13686
18. C. Badowski, G. Pawlak, A. Grichine, and et al. Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization Mol. Biol. Cell 19 2008 633 645
19. E.T. Bowden, M. Barth, D. Thomas, and et al. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation Oncogene 18 1999 4440 4449
20. H.O. Jin, I.C. Park, S. An, and et al. Up-regulation of Bak and Bim via JNK downstream pathway in the response to nitric oxide in human glioblastoma cells J. Cell Physiol. 206 2006 477 486
21. K. Tamura, H. Wakimoto, A.S. Agarwal, and et al. Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors Mol. Ther. 21 2013 68 77
22. K. Matsuda, A. Sato, M. Okada, and et al. Targeting JNK for therapeutic depletion of stem-like glioblastoma cells Sci. Rep. 2 2012 516
23. C.T. Hu, C.C. Cheng, J.R. Wu, and et al. PKCε-mediated c-Met endosomal processing directs fluctuant c-Met-JNK-paxillin signaling for tumor progression of HepG2 Cell Signal 27 2015 1544 1555
24. M.S. Lee, S. Kim, and B.G. Kim Snail1 induced in breast cancer cells in 3D collagen I gel environment suppresses cortactin and impairs effective invadopodia formation Biochim. Biophys. Acta 1843 2014 2037 2054
25. S.S. Stylli, A.H. Kaye, and P. Lock Invadopodia: at the cutting edge of tumour invasion J. Clin. Neurosci. 15 2008 725 737 Review
26. H. Shi, Y. Cheng, J. Ye, and et al. bFGF promotes the migration of human dermal fibroblasts under diabetic conditions through reactive oxygen species production via the PI3K/Akt-Rac1- JNK pathways Int. J. Biol. Sci. 11 2015 845 859
27. K.E. Scott, F.B. Wheeler, A.L. Davis, and et al. Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis PLoS One 7 2012 e29761